Hyundai has revealed the 11 hospitals that are receiving donations — and a Houston hospital made the list. Photo by Getty Images

As major corporations continue to react to the COVID-19 pandemic with relief and aid efforts, one automaker has decided to help fund testing in 11 children's hospital — and Houston-based Texas Children's Hospital has been named a beneficiary of the donation.

Last week, Hyundai Hope On Wheels and Hyundai Motor America announced that they were donating $2 million to 10 hospitals across the U.S. to aid with the operation of drive-thru coronavirus testing centers. This week, the two revealed that they upped the commitment, now offering help to 11 children's hospitals totaling $2.2 million.

"The Hyundai COVID-19 Drive-thru testing grants are designed to get urgent financial support to institutions on the front-line in the fight against the coronavirus," says José Muñoz, president and CEO of Hyundai Motor North America. "Children who are diagnosed with cancer are particularly at higher risk. That's why it was important to us to join forces with several children's hospitals around the nation to company this threat to the health and well-being of children. We are pleased to expand to 11 institutions nationwide, each with a $200,000 grant."

The other 10 hospitals receiving Hyundai COVID-19 Drive-Thru Testing grants are:

  • The Hyundai Cancer Institute at CHOC Children's, Orange, CA
  • UH Rainbow Babies and Children's, Cleveland, OH
  • Children's National Hospital, Washington, D.C.
  • Dana Farber / Boston Children's Hospital, Boston, MA
  • Seattle Children's Hospital, Seattle, WA
  • Columbia Medical Center, New York, NY
  • Joseph's Children's Hospital, Tampa, FL
  • Children's Hospital of Colorado, Aurora, CO
  • Children's Hospital of Philadelphia, Philadelphia, PA
  • University of Alabama Children's, Birmingham, AL

The Centers for Disease Control has built a website that offers resources to individuals who have questions about COVID-19, including how to identify symptoms, get tested, and decontaminate your home at www.cdc.gov.

------

This article originally ran on AutomotiveMap.

Ad Placement 300x100
Ad Placement 300x600

CultureMap Emails are Awesome

TMC launches new biotech partnership with Republic of Korea

international collaboration

Houston's Texas Medical Center has launched its new TMC Republic of Korea BioBridge.

The new partnership brings together the TMC with the Osong Medical Innovation Foundation, or KBIOHealth. The Biobridge aims to support the commercialization of Korean biotech and life science startups in the U.S., foster clinical research, and boost collaboration in the public, private and academic sectors.

Through the partnership, TMC will also develop a Global Innovators Launch Pad to foster U.S. market entry for international health care companies. Founders will be selected to participate in the 10-week program at the TMC Innovation Factory in Houston.

“Gene and cell therapies are driving biotech innovation, opening possibilities for treating diseases once thought untreatable," William McKeon, president and CEO of the Texas Medical Center, said in a news release. "Expanding biomanufacturing capacity is essential to delivering the next wave of these therapies, and partnerships with leading innovators will strengthen our efforts in Houston and internationally.”

McKeon officially signed the TMC Korea BioBridge Memorandum of Understanding with Myoung Su Lee, chairman of KBIOHealth, in South Korea in October.

"This collaboration marks a significant milestone for Korea’s biohealth ecosystem, creating a powerful bridge between Osong and Houston," Lee added in the release. "By combining KBIOHealth’s strength in research infrastructure and Korea’s biotech talent with TMC’s global network and accelerator platform, we aim to accelerate innovation and bring transformative solutions to patients worldwide.”

This is the seventh international strategic partnership for the TMC. It launched its first BioBridge with the Health Informatics Society of Australia in 2016. It launched its TMC Japan BioBridge, focused on advancing cancer treatments, last year. It also has BioBridge partnerships with the Netherlands, Ireland, Denmark and the United Kingdom.